Plaintiffs: Teva Pays $54M To Settle False Claims Suit Involving ‘Speaker’ Program
NEW YORK — Plaintiffs’ counsel on Jan. 6 said in a press release that Teva Pharmaceuticals Inc. agreed to pay $54 million to settle a whistle-blower lawsuit alleging that the drug...To view the full article, register now.
Already a subscriber? Click here to view full article